A carregar...
Targeted Therapies in HER2-Positive Breast Cancer – a Systematic Review
About 20% of all breast cancer patients have a human epidermal growth factor receptor 2 (HER2)-positive breast tumor. This entity underwent an impressive change in prognosis, with notable improvement of progression-free survival and overall survival. Due to more aggressive tumors and no specific the...
Na minha lista:
| Publicado no: | Breast Care (Basel) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger Verlag für Medizin und Naturwissenschaften GmbH
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4569208/ https://ncbi.nlm.nih.gov/pubmed/26557822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000431029 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|